Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Vaxon Biotech S.A.. (12/1/14). "Press Release: Vaxon Biotech Randomizes the 110th Patient in Its Oncology Vaccine Phase IIB Clinical Study in NSCLC. Oncology Vaccine Vx-001 Is the Only One in the World to Use Optimized Cryptic Peptides". Paris. 2014-12-01
Accovion GmbH. (12/1/14). "Press Release: Accovion Launches New Subsidiary in France". Frankfurt & Eschborn. 2014-12-01
GamaMabs Pharma S.A.. (11/27/14). "Press Release: GamaMabs Pharma Signs a Collaboration Agreement with Mayo Clinic". Toulouse. 2014-11-27
Neovacs S.A.. (11/24/14). "Press Release: Neovacs Granted 1 Million Europe in Research Tax Credit". Paris. 2014-11-24
Stallergenes S.A.. (11/20/14). "Press Release: Stallergenes and ActoGenix to Develop an Innovative New Class of Oral Allergy Treatments". Antony & Ghent. 2014-11-20
bioMérieux S.A.. (11/18/14). "Press Release: bioMérieux and Illumina Enter Agreement to Co-Develop a Next-generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections". Marcy l’Étoile & San Diego, CA. 2014-11-18
Sofimac Partners. (11/17/14). "Communiqué de Presse: Theranexus Lève avec Succès 3,6 M€ en Amorçage". 2014-11-17
Novasep S.A.. (11/13/14). "Press Release: Novasep and Partner Nilsan Nishotech to Install the First Continuous Chromatography System at Laurus Labs". Pompey. 2014-11-13
Enterome Bioscience S.A.. (11/12/14). "Press Release: Enterome Enters into a Microbiome-based Development Collaboration with AbbVie in Crohn’s Disease". Paris. 2014-11-12
Servier. (11/12/14). "Press Release: Intarcia and Servier Sign Ex-U.S. Partnership for ITCA 650 in Diabetes, Intarcia Retains Independence and Full Control of the U.S. and Japan". Boston, MA. 2014-11-12
Diaxonhit S.A.. (11/12/14). "Press Release: Renewal of Commercial Partnership with One Lambda, Inc. for Diagnostic Tests in Transplantation". Paris. 2014-11-12
Cellectis S.A.. (11/12/14). "Press Release: Cellectis Received Proceeds of €13 Million through the Exercise of Warrants". Paris. 2014-11-12
Valneva S.E.. (11/6/14). "Press Release: Valneva Announces Best Quarterly Results Since Vivalis/Intercell Merger, Meets Business Objectives amd Reconfirms Full Year Outlook". Lyon. 2014-11-06
Carlina Technologies. (11/4/14). "Press Release: Carlina Technologies Signs a Partnership Agreement with Genbiotech to Develop a Sustained-release Protein Formulation for Cartilage Repair". Angers. 2014-11-04
Abivax S.A.. (10/30/14). "Press Release: Abivax Strengthens Executive Management Team with Senior Appointments Karl Birthistle, M.D., Appointed VP of Global Regulatory Affairs Daniel Kenny Appointed Chief Commercial Officer & VP of Business Development". 2014-10-30
Novacyt S.A.. (10/30/14). "Press Release: Novacyt Announces 2014 Half Year Results and Updates Strong Progress with Integration of Lab21". Paris & Cambridge. 2014-10-30
Polyplus-transfection S.A.. (10/28/14). "Press Release: Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement for Use of PEI-based Transfection Technologies". Strasbourg. 2014-10-28
bioMérieux S.A.. (10/22/14). "Press Release: Business Review for the Nine Months Ended September 30, 2014". Marcy l’Étoile. 2014-10-22
Transgene S.A.. (10/21/14). "Press Release: Transgene Announces Third Quarter 2014 Financial Results". Strasbourg. 2014-10-21
bioMérieux S.A.. (10/10/14). "Press Release: bioMérieux Inaugurates a New Multidisciplinary R&D Center for Infectious Disease Diagnostics". Marcy l’Étoile. 2014-10-10
Novasep S.A.. (10/2/14). "Press Release: Novasep to Sell Its Bahamian Plant to Local Investor". Pompey. 2014-10-02
VitamFero S.A.. (9/30/14). "Press Release: VitamFero Successfully Secures Its Third Round of Financing". 2014-09-30
Bionomics Ltd.. (9/23/14). "Press Release: Bionomics Acquires Prestwick Chemical. Pre-existing Business Integration and Strong Synergies". 2014-09-23
Vexim S.A.. (9/22/14). "Press Release: Vexim Announces Strong 2014 Half-year Results". Toulouse. 2014-09-22
bioMérieux S.A.. (9/18/14). "Press Release: bioMérieux Launches chromID Salmonella Elite, the New Generation of Culture Media for Earlier Detection of Salmonella Strains in Clinical Fecal Smaples". Marcy l’Étoile. 2014-09-18
Innate Pharma S.A.. (9/17/14). "Press Release: First Half of 2014 – Broadened Clinical Portfolio and Strengthened Cash Position". 2014-09-17
Novacyt S.A.. (9/17/14). "Press Release: Novacyt Appoints Anthony Dyer as Finance Director". Paris & Cambridge. 2014-09-17
Alizé Pharma S.A.S.. (9/10/14). "Press Release: Alizé Pharma Raises EUR 5 Million (USD 6.6 Million) from Bpifrance/InnoBio and Its Existing Shareholders". Lyon. 2014-09-10
Poxel S.A.. (9/9/14). "Press Release: Poxel Raises EUR10 Million from New Investors to Progress Clinical Development of Two Novel Type 2 Diabetes Therapies". Lyon. 2014-09-09
Vexim S.A.. (9/8/14). "Press Release: Vexim Opens U.S. Subsidiary. Office to Support Vexim’s Product Portfolio Launch in the U.S.". Toulouse. 2014-09-08
Cellectis S.A.. (9/4/14). "Press Release: Cellectis Announces the Closing of the Sale of Its Swedish Subsidiary Cellectis AB to Takara Bio Inc.". Paris. 2014-09-04
bioMérieux S.A.. (9/3/14). "Press Release: First-half 2014 Results". Marcy l’Étoile. 2014-09-03
Cepheid. (9/3/14). "Press Release: Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections". Sunnyvale, CA. 2014-09-03
Vygon S.A.. (9/2/14). "Press Release: Vygon Group Buys Medwin". Ecouen. 2014-09-02
Cepheid. (9/2/14). "Press Release: Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection". Sunnyvale, CA. 2014-09-02
Median Technologies S.A.. (8/25/14). "Press Release: Median Technologies Announces a Reserved Capital Increase of €20 Million. Investment Led by New Enterprise Associates (NEA), a Leading US Healthcare Investor". Sophia Antipolis. 2014-08-25
Valneva S.E.. (8/8/14). "Press Release: Valneva Reports H1 2014 Results, Confirms Full Year Outlook, and Provides Business Update". Lyon. 2014-08-08
Cellectis S.A.. (7/31/14). "Press Release: Pfizer’s Stake in Cellectis’ Capital Is Welcomed by Its Shareholders". Paris. 2014-07-31
Cellectis S.A.. (7/29/14). "Press Release: Cellectis Sells Its Swedish Subsidiary, Cellectis AB, to the Japanese Company Takara Bio Inc.". Paris. 2014-07-29
bioMérieux, Inc.. (7/23/14). "Press Release: bioMérieux Virtuo, the New Generation of Blood Culture System, Is CE-marked". Marcy l’Étoile. 2014-07-23
Novasep S.A.. (7/22/14). "Press Release: Novasep Passes FDA Inspections on Two Sites. Novasep Wins Approval to Produce New Molecular Entity for US Market". Pompey. 2014-07-22
bioMérieux S.A.. (7/17/14). "Press Release: Second-Quarter 2014 Business Review – Solid Growth in First-half Sales ". Marcy l’Étoile. 2014-07-17
Innate Pharma S.A.. (6/24/14). "Press Release: Innate Pharma Raises 50 Million Euros in a Capital Increase Subscribed by Specialist Institutional Investors [Not for Canada, Australia or Japan]". Marseille. 2014-06-24
Innate Pharma S.A.. (6/19/14). "Press Release: Innate Pharma Launches a Capital Increase to Raise Up to 15% of Current Capital [Not for Canada, Australia or Japan]". Marseille. 2014-06-19
Pfizer Inc.. (6/18/14). "Press Release: Pfizer and Cellectis Enter into Global Strategic Cancer Immunotherapy Collaboration". 2014-06-18
Pixium Vision S.A.. (6/17/14). "Press Release: Pixium Vision Raises €34.5 Million (US$ 46.7 Million) in Successful IPO on Euronext Paris, after Full Exercise of the Extension Clause". Paris. 2014-06-17
Prestodiag S.A.S.. (6/10/14). "Press Release: Prestodiag Raises €2.2 Million Euro to Market Its Innovative Solutions for Microbiological Analysis". Paris. 2014-06-10
Cellectis S.A.. (6/5/14). "Press Release: Cellectis and Thermo Fisher Scientific Enter Into Agreements on TALEN, a Leading Gene Editing Technology". Carlsbad, CA & Paris. 2014-06-05
Provence Technologies. (6/2/14). "Press Release: Provence Technologies Acquires Synprosis". Marseille. 2014-06-02
bioMérieux S.A.. (5/28/14). "Press Release: The General Shareholders’ Meeting of bioMérieux Approves the Appointment of Two New Independent Directors". Marcy l’Étoile. 2014-05-28
Lysogene. (5/21/14). "Press Release: Lysogene Raises a 16.5 M€ Series A Led by Sofinnova Partners and Co-led by Innobio and Novo Seeds". Paris. 2014-05-21
Biovision (Fondation pour l’Universite de Lyon / Andrew Lloyd & Associates). (5/19/14). "Press Release: Biovision Presents Its Selection of 44 Promising Life Sciences Businesses and Projects". Lyon. 2014-05-19
Enterome Bioscience S.A.. (5/1/14). "Press Release: Enterome Raises €10 Million in Series B Fund Raising". Paris. 2014-05-01
Sartorius AG. (4/28/14). "Press Release: Sartorius Stedim Biotech Acquires Majority Stake in U.S. Start-up AllPure Technologies. Takeover Extends Sartorius Stedim Biotech Portfolio for Single-use Bioprocessing". Aubagne. 2014-04-28
Sartorius AG. (4/28/14). "Press Release: First-quarter Figures – Sartorius Stedim Biotech Off to a Good Start in 2014". 2014-04-28
bioMérieux S.A.. (4/23/14). "Press Release: First-quarter 2014 Business Review". Marcy l’Étoile. 2014-04-23
Transgene S.A.. (4/22/14). "Press Release: Transgene Reports First Quarter 2014 Financial Results. Circa € 100 Million in Cash as of March 31". Strasbourg. 2014-04-22
BioAlliance Pharma S.A.. (4/16/14). "Press Release: BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company". Paris & Copenhagen. 2014-04-16
Theradiag S.A.. (4/16/14). "Press Release: Theradiag Secures a Standby Equity Facility (SEF) with Société Générale". Croissy-Beaubourg & Montpellier. 2014-04-16
AAVLife. (4/15/14). "Press Release: AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia". Paris. 2014-04-15
bioMérieux S.A.. (4/15/14). "Press Release: Alexandre Mérieux Assumes Role of bioMérieux CEO". Marcy l’Étoile. 2014-04-15
Vexim S.A.. (4/15/14). "Press Release: Vexim Doubles Its Sales in the 1st Quarter of 2014, to €2.1m". Toulouse. 2014-04-15
IntegraGen S.A.. (4/15/14). "Press Release: Annual Results 2013". Evry. 2014-04-15
TxCell S.A.. (4/14/14). "Press Release: TxCell Completes IPO on Euronext, Raising EUR 16.2 Million [only for relevant persons]". Valbonne. 2014-04-14
Novasep S.A.. (5/15/14). "Press Release: Novasep’s EUR 4 Million Plant Extension for Commercial ADC Payload Manufacturing Now Commissioned". Pompey. 2014-04-14
Nanobiotix S.A.. (4/11/14). "Press Release: 2013 Annual Results". Paris. 2014-04-11
Immutep S.A.. (4/8/14). "Press Release: Immutep and Eddingpharm Start Production of ImmuFact IMP321 at WuXi AppTec in China". Orsay & Shanghai. 2014-04-08
Theradiag S.A.. (4/8/14). "Press Release: Theradiag Signs a Fourth microRNA Partnership Agreement with CNRS". Croissy-Beaubourg & Montpellier. 2014-04-08
Genticel S.A.. (4/4/14). "Press Release: Genticel Lists on Euronext in Paris and Brussels". 2014-04-04
IntegraGen S.A.. (4/3/14). "Press Release: IntegraGen Announces Collaborative Agreement with Pfizer to Evaluate IntegraGen’s Proprietary Hepatocellular Carcinoma Molecular Signature". 2014-04-03
Novasep S.A.. (3/27/14). "Press Release: Novasep Reports Full Year 2013 Results Showing Strong Growth and Beating Guidance". 2014-03-27
Neovacs S.A.. (3/27/14). "Press Release: Financial Results for 2013". Paris. 2014-03-27
Adocia S.A.. (3/25/14). "Adocia Announces Financial Results for 2013. A Cash Position of EUR 19.4M at End of December 2013". Lyon. 2014-03-25
IntegraGen S.A.. (3/24/14). "Press Release: IntegraGen and Gustave Roussy Announce the Set-up of a High-throughput Clinical Sequencing Unit". Villejuif. 2014-03-24
Transgene S.A.. (3/24/14). "Press Release: Transgene Successfully Completes Rights Issue and Private Placement. Total of €65.5 Million Raised [Not for distribution in or into Canada, Japan or Australia]". Strasbourg. 2014-03-24
Valneva S.E.. (3/24/14). "Press Release: Valneva Reports Annual Results 2013. Company Sees First Year of Merger as Operational and Human Success". Lyon. 2014-03-24
Valneva S.E.. (3/24/14). "Press Release: Valneva Announces Continuation of the Phase II/III Clinical Trial for Its Pseudomonas Aeurginosa Vaccine Candidate". Lyon. 2014-03-24
Theradiag S.A.. (3/21/14). "Press Release: Theradiag Selected as a Partner of the ABIRISK Project, the First Consortium of Pharmaceuticals and Academic Experts Dedicated to the Monitoring of Biotherapies". Croissy-Beaubourg & Montpellier. 2014-03-21
Adocia S.A.. (3/20/14). "Press Release: Adocia Confirms Positive Clinical Results for Its BioChaperone Combo, a Combination of Long-acting Insulin Glargine and Fast-acting Insulin Lispro". Lyon. 2014-03-20
bioMérieux S.A.. (3/19/14). "Press Release: 2013 Financial Results". Marcy l’Étoile. 2014-03-19
Inserm Transfert. (3/18/14). "Press Release: Mrs Pascale Augé Appointed as Chief Executive Officer, Inserm Transfert". 2014-03-18
Inserm Transfert. (3/18/14). "Press Release: Cécile Tharaud Appointed as President and Managing Partner of Inserm Transfert Initiative". 2014-03-18
Inotrem S.A.. (3/13/14). "Press Release: Inotrem Raises EUR18 Million to Develop Innovative Sepsis Treatments in a Series A Financing Co-led by Edmond de Rothschild Investment Patners and Sofinnova Partners". Paris & Nancy. 2014-03-13
Innovative Medicines Initiative (IMI). (3/11/14). "Press Release: New IMI Project to Incorporate Real Life Data into Drug Development". Brussels. 2014-03-11
Sanofi S.A.. (3/11/14). "Press Release: Sanofi and UCB Partner for Breakthrough Innovation in Immune-mediated Diseases". Paris. 2014-03-11
Bureau Veritas S.A.. (3/6/14). "Press Release: Solid Financial Performance in 2013. Revenue of EUR 3.9 Billion, +5.5% at Constant Currencies". 2014-03-06
Curie-Cancer. (3/5/14). "Press Release: Curie-Cancer and DNA Therapeutics Partner in the Fight against Cancers that Resist Conventional Therapies". Paris & Evry. 2014-03-05
Novasep S.A.. (3/4/14). "Press Release: Novasep Appoints CEO Michel Spagnol as Chairman of the Supervisory Board, Novasep Presents Strategic Developments". Pompey. 2014-03-04
Ynsect S.A.. (3/4/14). "Press Release: Ynsect Raises 1.8 Million Euro in Series A Funding to Develop Insect Biorefineries". 2014-03-04
GamaMabs Pharma S.A.. (3/3/14). "Press Release: GamaMabs Pharma Announces Two Financings Totaling €1.1 Million". Toulouse. 2014-03-03
Transgene S.A.. (2/28/14). "Press Release: Transgene Launches a Rights Issue of 45.5 Million Euros at a Price of 10 Euros per Share [Not for distribution into Canada, Japan or Australia]". Strasbourg. 2014-02-28
Adocia S.A.. (2/27/14). "Press Release: Adocia Announces Preliminary Positive Clinical Results for Its Combination of Long-acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo". Lyon. 2014-02-27
bioMérieux S.A.. (2/26/14). "Press Release: bioMérieux Strengthens Its Clostridium difficile Offer with the Launch of VIDAS C. difficile GDH". Marcy l’Étoile. 2014-02-26
Transgene S.A.. (2/25/14). "Press Release: Transgene Announces Plans for a Phase 1b/2 Trial with Pexa-Vec in Advanced Solid Tumors". Strasbourg. 2014-02-25
Adocia S.A.. (2/18/14). "Press Release: Adocia – Annual Revenue of EUR 5.6 M in 2013. The cash position of the Company Amounts to EUR 19.4 M". Lyon. 2014-02-18
Polyplus-transfection S.A.. (2/17/14). "Press Release: Polyplus-transfection and the National Institute of Health Sign a Research License Agreement for PEI-based Transfection Technologies". Strasbourg. 2014-02-17
Truffle Capital. (2/12/14). "Press Release: Creation of Abivax – a Leader in Therapeutic Vaccines and the First French Company to Sign an Exclusive Partnering Agreement with Cuba in Healthcare". Paris. 2014-02-12
Biovision. (2/11/14). "Press Release: Biovision Will Explore Ways to Identify and Fund Disruptive Innovation in Healthcare – June 5 and 6 2014". Lyon. 2014-02-11
Innate Pharma S.A.. (2/11/14). "Press Release: Annual Results for 2013. Cash Position Strengthened to €41.3m as at December 31, 2013". Marseille. 2014-02-11
Cellectis S.A.. (2/4/14). "Press Release: Cellectis Grants genOway an Exlusive Sublicense for Its Homologous Recombination Technology in the Field of Genetically Modified Rodent Models". Paris. 2014-02-04
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top